Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Foerster

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Hepatobiliary Surgery and Nutrition|December 12, 2025
Performance of major liver resection for gallbladder cancer-a western retrospective single center cohort studyConstantin Scholz, Maria Hoppe-Lotichius, Arndt Weinmann, et al.
Journal of Hepatology|March 22, 2017
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapyPeter R Galle, Francesco Tovoli, Friedrich Foerster, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 21, 2023
Quantum iterative reconstruction on a photon-counting detector CT improves the quality of hepatocellular carcinoma imagingDirk Graafen, Fabian Stoehr, Moritz C Halfmann, et al.
Scientific Reports|March 31, 2018
The immune contexture of hepatocellular carcinoma predicts clinical outcomeFriedrich Foerster, Moritz Hess, Aslihan Gerhold-Ay, et al.
United European Gastroenterology Journal|July 19, 2019
Long-term observation of hepatocellular carcinoma recurrence after liver transplantation at a European transplantation centreFriedrich Foerster, Maria Hoppe-Lotichius, Johanna Vollmar, et al.
Cancers|July 27, 2022
Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under ImmunotherapyLukas Müller, Simon Johannes Gairing, Roman Kloeckner, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 25, 2023
Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimatesLukas Müller, Simon J Gairing, Friedrich Foerster, et al.
Zeitschrift Fur Gastroenterologie|January 11, 2021
Multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension - case-report-based discussionSimon J Gairing, Roman Kloeckner, Michael B Pitton, et al.
Future Oncology (London, England)|May 17, 2021
A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancerMarkus Moehler, Maurice Michel, Alexander Stein, et al.
Advanced Healthcare Materials|December 3, 2015
In Vivo Gene-Silencing in Fibrotic Liver by siRNA-Loaded Cationic Nanohydrogel ParticlesLeonard Kaps, Lutz Nuhn, Misbah Aslam, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Hepatobiliary Surgery and Nutrition|December 12, 2025
Performance of major liver resection for gallbladder cancer-a western retrospective single center cohort studyConstantin Scholz, Maria Hoppe-Lotichius, Arndt Weinmann, et al.
Journal of Hepatology|March 22, 2017
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapyPeter R Galle, Francesco Tovoli, Friedrich Foerster, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 21, 2023
Quantum iterative reconstruction on a photon-counting detector CT improves the quality of hepatocellular carcinoma imagingDirk Graafen, Fabian Stoehr, Moritz C Halfmann, et al.
Scientific Reports|March 31, 2018
The immune contexture of hepatocellular carcinoma predicts clinical outcomeFriedrich Foerster, Moritz Hess, Aslihan Gerhold-Ay, et al.
United European Gastroenterology Journal|July 19, 2019
Long-term observation of hepatocellular carcinoma recurrence after liver transplantation at a European transplantation centreFriedrich Foerster, Maria Hoppe-Lotichius, Johanna Vollmar, et al.
Cancers|July 27, 2022
Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under ImmunotherapyLukas Müller, Simon Johannes Gairing, Roman Kloeckner, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 25, 2023
Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimatesLukas Müller, Simon J Gairing, Friedrich Foerster, et al.
Zeitschrift Fur Gastroenterologie|January 11, 2021
Multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension - case-report-based discussionSimon J Gairing, Roman Kloeckner, Michael B Pitton, et al.
Future Oncology (London, England)|May 17, 2021
A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancerMarkus Moehler, Maurice Michel, Alexander Stein, et al.
Advanced Healthcare Materials|December 3, 2015
In Vivo Gene-Silencing in Fibrotic Liver by siRNA-Loaded Cationic Nanohydrogel ParticlesLeonard Kaps, Lutz Nuhn, Misbah Aslam, et al.
Pageof 6